THIRD AVENUE MANAGEMENT LLC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 1099281
NEW YORK, NY
Position in COLL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,611,749
+$1,481,170 QoQ
Shares Held
182,645
+17.7% QoQ
Ownership
0.561%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#38
of 280 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026THIRD AVENUE MANAGEMENT LLC holds $13,714,942 across 2 Drug Manufacturers - Specialty & Generic names. COLL ranks #2 (48.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
152,724 | $7,103,193 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
This page
|
182,645 | $6,611,749 |
All Filings in COLL
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,611,749 | 182,645 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,130,579 | 155,143 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,417,466 | 203,401 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,117,000 | 203,401 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,014,567 | 203,401 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,071,519 | 203,401 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,827,438 | 203,401 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,057,634 | 182,651 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,869,448 | 182,281 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,197,218 | 108,120 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,558,433 | 83,120 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||